Cite
Imamura M, Seki T, Kunieda K, et al. Hydroxyapatite beads containing Doxorubicin hydrochloride (dox) and buthionine sulfoximine (bso) - a new anticancer drug design for local treatment with multiple-drugs. Oncol Rep. 1995;2(1):33-6doi: 10.3892/or.2.1.33.
Imamura, M., Seki, T., Kunieda, K., Nakatani, S., Inoue, K., Nakano, T., & Harada, K. (1995). Hydroxyapatite beads containing Doxorubicin hydrochloride (dox) and buthionine sulfoximine (bso) - a new anticancer drug design for local treatment with multiple-drugs. Oncology reports, 2(1), 33-6. https://doi.org/10.3892/or.2.1.33
Imamura, M, et al. "Hydroxyapatite beads containing Doxorubicin hydrochloride (dox) and buthionine sulfoximine (bso) - a new anticancer drug design for local treatment with multiple-drugs." Oncology reports vol. 2,1 (1995): 33-6. doi: https://doi.org/10.3892/or.2.1.33
Imamura M, Seki T, Kunieda K, Nakatani S, Inoue K, Nakano T, Harada K. Hydroxyapatite beads containing Doxorubicin hydrochloride (dox) and buthionine sulfoximine (bso) - a new anticancer drug design for local treatment with multiple-drugs. Oncol Rep. 1995 Jan;2(1):33-6. doi: 10.3892/or.2.1.33. PMID: 21597683.
Copy
Download .nbib